Valeo Pharma Announces Short Form Prospectus Unit Offering and Refiling of Its Condensed Consolidated Interim Financial Statements and Related MD&A

    NEXT STORY
    Innovation Pharmaceuticals Receives FDA End-of-Phase 2 Meeting Minutes
    PREV STORY
    Allogene Therapeutics Announces Expansion of Scientific Advisory Board
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Baudax Bio Announces Presentation of New Phase IIIb ANJESO™ Data at the 45th Annual Regional Anesthesiology and Acute Pain Medicine Meeting

    author_avatar
    NASDAQ Market News

    Global Peptide And Anticoagulant Drugs Market Will Reach USD 1,860 Million By 2025: Zion Market Research

    author_avatar
    NASDAQ Market News

    ESMO Asia 2017: Oraxol (oral paclitaxel, Athenex) Can Achieve Similar Exposure to IV Paclitaxel in Cancer Patients

    BUFFALO, N.Y., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

    author_avatar
    NASDAQ Market News